Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (435) 435
Publication (37) 37
Newspaper Article (23) 23
Book Chapter (9) 9
Dissertation (8) 8
Book / eBook (6) 6
Book Review (4) 4
Conference Proceeding (3) 3
Magazine Article (3) 3
Patent (1) 1
Reference (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (135) 135
humans (105) 105
hematology (91) 91
female (79) 79
male (76) 76
middle aged (70) 70
aged (66) 66
oncology (53) 53
adult (49) 49
multiple myeloma (49) 49
survival (48) 48
amyloidosis (42) 42
transplantation (35) 35
aged, 80 and over (33) 33
stem cells (33) 33
care and treatment (32) 32
retrospective studies (32) 32
treatment outcome (32) 32
prognosis (31) 31
analysis (30) 30
patients (30) 30
diagnosis (26) 26
therapy (26) 26
abridged index medicus (24) 24
article (24) 24
dexamethasone (23) 23
hematology, oncology and palliative medicine (22) 22
survival analysis (22) 22
follow-up studies (19) 19
bortezomib (17) 17
chemotherapy (17) 17
patient outcomes (17) 17
mortality (16) 16
multiple-myeloma (16) 16
stem cell transplantation (16) 16
stem-cell transplantation (16) 16
al amyloidosis (15) 15
autografts (15) 15
cardiac biomarkers (15) 15
multiple myeloma - mortality (15) 15
research (15) 15
bone marrow (14) 14
cancer (14) 14
medical research (14) 14
medicine, experimental (14) 14
outcomes (14) 14
staging system (14) 14
immunology (13) 13
lenalidomide (13) 13
medicine, general & internal (13) 13
myeloma (13) 13
complications and side effects (12) 12
risk factors (12) 12
survival rate (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
health aspects (11) 11
light-chain amyloidosis (11) 11
melphalan (11) 11
multiple myeloma - diagnosis (11) 11
multiple myeloma - drug therapy (11) 11
transplants & implants (11) 11
young adult (11) 11
biopsy (10) 10
combined modality therapy (10) 10
immunoglobulins (10) 10
medical prognosis (10) 10
relapse (10) 10
risk (10) 10
transplantation, autologous (10) 10
usage (10) 10
animals (9) 9
criteria (9) 9
disease progression (9) 9
disease-free survival (9) 9
impact (9) 9
international staging system (9) 9
monoclonal gammopathy (9) 9
mutation (9) 9
neoplasms. tumors. oncology. including cancer and carcinogens (9) 9
plasma cells (9) 9
primary systemic amyloidosis (9) 9
united states (9) 9
adolescent (8) 8
amyloidosis - therapy (8) 8
article subject (8) 8
child (8) 8
development and progression (8) 8
drug therapy (8) 8
high-dose melphalan (8) 8
kaplan-meier estimate (8) 8
multiple myeloma - pathology (8) 8
multiple myeloma - therapy (8) 8
plasma (8) 8
progression (8) 8
recurrence (8) 8
amyloidosis - diagnosis (7) 7
antineoplastic agents - therapeutic use (7) 7
case report (7) 7
clinical trials (7) 7
dexamethasone - administration & dosage (7) 7
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Faculty of Information - Stacks (1) 1
OISE - Curriculum Resources (1) 1
Trinity College (John W Graham) - Reference (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Plasmacytomas: many faces of one disease, or many diseases with one face?
by Goyal, Gaurav and Gonsalves, Wilson I
Oncotarget, ISSN 1949-2553, 01/2019, Volume 10, Issue 3, p. 257
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Editorial plasmacytomas: Many faces of one disease, or many diseases with one face?
by Goyal, Gaurav and Gonsalves, Wilson I
Oncotarget, 01/2019, Volume 10, Issue 3, pp. 257 - 258
Plasmacytoma | Myeloma | Outcomes | Radiation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Treatment approaches and outcomes in extramedullary plasmacytomas
by Goyal, Gaurav and Bartley, Adam C and Gonsalves, Wilson I and Kumar, Shaji
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 8050 - 8050
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Clinical Features and Outcomes of Plasmacytoma in the United States: Analysis Using the National Cancer Data Base
by Goyal, Gaurav and Gonsalves, Wilson I and Go, Ronald S and Kumar, Shaji
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3249 - 3249
Abstract Introduction Plasmacytomas comprise approximately 3% of all plasma cell malignancies. There is a paucity of large studies assessing clinical features... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Should we measure clonal circulating plasma cells in light chain amyloidosis?
by Sidana, Surbhi and Kumar, Shaji K and Gonsalves, Wilson I
Oncotarget, ISSN 1949-2553, 11/2018, Volume 9, Issue 86, pp. 35607 - 35608
Amyloidosis | Clonal plasma cells | Myeloma | Circulating plasma cells | Light chain
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Disparity in early mortality among racial groups with multiple myeloma in the United States: A National Cancer Data Base study of 108,352 patients
by Gonsalves, Wilson I and Bartley, Adam C and Go, Ronald S
Journal of Clinical Oncology, ISSN 0732-183X, 03/2016, Volume 34, Issue 7_suppl, pp. 311 - 311
311 Background: Previous population-based studies have shown variations in disease incidence and overall survival (OS) among multiple myeloma (MM) patients... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Trial in Progress: Phase I Dose-Escalation and Dose-Expansion Trial of a Novel Glutaminase Inhibitor (CB-839 HCl) in Combination with Carfilzomib and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
by Gonsalves, Wilson I and Devarakonda, Srinivas and Baz, Rachid and Neparidze, Natalia and Adjei, Alex A and Kunos, Charles and Kumar, Shaji K
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3160 - 3160
Background: c-MYC activation is an early event of myeloma pathogenesis. It upregulates the expression of the glutaminase 1 (GLS1) enzyme which converts... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text The New Oral Anticoagulants in Clinical Practice
by Gonsalves, Wilson I., MD and Pruthi, Rajiv K., MBBS and Patnaik, Mrinal M., MBBS
Mayo Clinic Proceedings, ISSN 0025-6196, 2013, Volume 88, Issue 5, pp. 495 - 511
Abstract Vitamin K antagonists were the only class of oral anticoagulants available to clinicians for decades. However, with the US Food and Drug... 
Internal Medicine | ENOXAPARIN | MEDICINE, GENERAL & INTERNAL | DIRECT THROMBIN INHIBITOR | KNEE REPLACEMENT | DABIGATRAN ETEXILATE | VENOUS THROMBOEMBOLISM | STROKE PREVENTION | WARFARIN | RIVAROXABAN | DOUBLE-BLIND | NONVALVULAR ATRIAL-FIBRILLATION | Anticoagulants - administration & dosage | Thiophenes - adverse effects | Humans | beta-Alanine - pharmacokinetics | Thiophenes - administration & dosage | Dabigatran | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | Benzimidazoles - adverse effects | Pyrazoles - pharmacokinetics | beta-Alanine - analogs & derivatives | Morpholines - adverse effects | Pyrazoles - adverse effects | beta-Alanine - adverse effects | Pyridones - pharmacokinetics | Administration, Oral | Morpholines - administration & dosage | beta-Alanine - administration & dosage | Benzimidazoles - pharmacokinetics | Treatment Outcome | Anticoagulants - adverse effects | Thiophenes - pharmacokinetics | Pyrazoles - administration & dosage | Anticoagulants - pharmacokinetics | Morpholines - pharmacokinetics | Pyridones - adverse effects | Complications and side effects | Usage | Anticoagulants (Medicine) | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text 59-Year-Old Man With Fatigue, Weight Loss, and Hepatomegaly
by Orme, Jacob J and Sidana, Surbhi and Gonsalves, Wilson I
Mayo Clinic Proceedings, ISSN 0025-6196, 10/2018, Volume 93, Issue 10, pp. 1525 - 1529
A 59-year-old man with type 2 diabetes, hypertension, and hyperlipidemia presented to his primary care physician with a 2-year history of fatigue and a 30-kg... 
MULTIPLE-MYELOMA | MEDICINE, GENERAL & INTERNAL | LIGHT-CHAIN AMYLOIDOSIS | AL AMYLOIDOSIS | FAILURE | Immunohistochemistry | Cyclophosphamide - administration & dosage | Hepatomegaly - diagnostic imaging | Humans | Image-Guided Biopsy - methods | Middle Aged | Immunoglobulin Light-chain Amyloidosis - diagnosis | Fatigue - etiology | Tomography, X-Ray Computed - methods | Male | Antineoplastic Agents - administration & dosage | Cardiomyopathies - etiology | Splenomegaly - diagnostic imaging | Peritoneal Neoplasms - diagnosis | Amyloid - metabolism | Cardiomyopathies - diagnosis | Peptide Fragments - blood | Splenomegaly - etiology | Natriuretic Peptide, Brain - blood | Peritoneal Neoplasms - pathology | Cardiomyopathies - blood | Dexamethasone - administration & dosage | Treatment Outcome | Fatigue - diagnosis | Bortezomib - administration & dosage | Weight Loss | Immunoglobulin Light-chain Amyloidosis - metabolism | Immunoglobulin Light-chain Amyloidosis - physiopathology | Hepatomegaly - etiology | Type 2 diabetes | Medicine | Complications and side effects | Care and treatment | Hepatomegaly | Practice | Diagnosis | Tests, problems and exercises | Immunoglobulins | Nuclear magnetic resonance--NMR | Medical imaging | Hematology | Mortality | Multiple myeloma | Fatigue | Chromatography | Abdomen | Stains & staining | Proteins | Chemotherapy | Scientific imaging | Diabetes | Blood diseases | Mass spectrometry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Early Mortality in Multiple Myeloma: Risk Factors and Impact on Population Outcomes
by Costa, Luciano J and Gonsalves, Wilson I and Kumar, Shaji
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1320 - 1320
Abstract Background: There has been major improvement in the survival of patients diagnosed with multiple myeloma (MM) over the past two decades. Such... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Second Autologous Hematopoietic Stem Cell Transplant as Salvage Therapy for Relapsed Multiple Myeloma: A Global Treatment Option for Eligible Patients
by Gonsalves, Wilson I and Kansagra, Ankit
Acta Haematologica, ISSN 0001-5792, 02/2018, Volume 139, Issue 1, pp. 45 - 46
Editorial Comment | HEMATOLOGY | Recurrence | Retreatment | Multiple Myeloma - pathology | Multiple Myeloma - therapy | Humans | Hematopoietic Stem Cell Transplantation - adverse effects | Salvage Therapy | Treatment Outcome | Hematopoietic Stem Cell Transplantation - methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Association of metformin with reduced mortality in patients with colorectal cancer: A systematic review and meta-analysis of observational studies
by Singh, Preet Paul and Singh, Siddharth and Gonsalves, Wilson I and Grothey, Axel
Journal of Clinical Oncology, ISSN 0732-183X, 01/2014, Volume 32, Issue 3_suppl, pp. 522 - 522
522 Background: Metformin inhibits mTOR and downstream pathways involved in cell proliferation and survival by inducing AMPK activation. Although its use has... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Functional Interrogation of Variants of Undetermined Significance of the Isocitrate Dehydrogenase 1 and 2 Genes in Myeloid Neoplasms
by Lasho, Terra and Tischer, Alexander and Antelo, Guadalupe Belen and Pardanani, Animesh and Finke, Christy and Coltro, Giacomo and Gonsalves, Wilson I and Tefferi, Ayalew and Mangaonkar, Abhishek A and Gangat, Naseema and Patnaik, Mrinal M
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1697 - 1697
Introduction: Isocitrate dehydrogenase 1 and 2 (IDH1/2) are metabolic enzymes in the citric acid cycle, producing alpha-ketoglutarate (αKG). Mutations in... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text In reply - Abigatran for heparin-induced thrombocytopenia
by Gonsalves, Wilson I and Pruthi, Rajiv K and Patnaik, Mrinal M
Mayo Clinic Proceedings, ISSN 0025-6196, 2013, Volume 88, Issue 9, pp. 1036 - 1037
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Combination therapy incorporating Bcl‐2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14)
by Gonsalves, Wilson I and Buadi, Francis K and Kumar, Shaji K
European Journal of Haematology, ISSN 0902-4441, 02/2018, Volume 100, Issue 2, pp. 215 - 217
Primary plasma cell leukemia (pPCL) is the most aggressive form of the plasma cell (PC) malignancy, multiple myeloma (MM). It has been commonly associated with... 
Bcl‐2 inhibition | plasma cell leukemia | Venetoclax | Bcl-2 inhibition | SURVIVAL | HEMATOLOGY | MYELOMA | Care and treatment | Leukemia | Plasma | Immunoglobulins | Bortezomib | Dexamethasone | Bcl-2 protein | Multiple myeloma | Heavy chains | Clinical trials | Plasma cell leukemia | Malignancy | Chromosome 14
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147
by Gonsalves, Wilson I and Mahoney, Michelle R and Sargent, Daniel J and Nelson, Garth D and Alberts, Steven R and Sinicrope, Frank A and Goldberg, Richard M and Limburg, Paul J and Thibodeau, Stephen N and Grothey, Axel and Hubbard, Joleen M and Chan, Emily and Nair, Suresh and Berenberg, Jeffrey L and McWilliams, Robert R and Alliance Clinical Trials Oncology and Alliance for Clinical Trials in Oncology
Journal of the National Cancer Institute, ISSN 0027-8874, 07/2014, Volume 106, Issue 7
Background KRAS and BRAF(V600E) mutations are important predictive and prognostic markers, respectively, in colon cancer, but little is known about patient and... 
ISLAND METHYLATOR PHENOTYPE | PATHOGENESIS | DNA MISMATCH REPAIR | CETUXIMAB | CIGARETTE-SMOKING | ONCOLOGY | CARCINOMAS | RANDOMIZED-TRIAL | ASSOCIATION | METASTATIC COLORECTAL-CANCER | CHEMOTHERAPY | ras Proteins - genetics | Colonic Neoplasms - genetics | Proto-Oncogene Proteins p21(ras) | Prospective Studies | Humans | Middle Aged | Logistic Models | Male | Proto-Oncogene Proteins - genetics | Aspartic Acid | Glycine | Glutamic Acid | Clinical Trials, Phase III as Topic | Neoplasm Grading | Molecular Epidemiology | Proto-Oncogene Proteins B-raf - genetics | Valine | Colonic Neoplasms - pathology | DNA Mismatch Repair | Adult | Female | Surveys and Questionnaires | Aged | Mutation | Colon cancer | Gene mutations | Genetic susceptibility | Genetic research | Genetic aspects | Research | Identification and classification | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time
by Sidiqi, M Hasib and Aljama, Mohammed A and Buadi, Francis K and Warsame, Rahma M and Lacy, Martha Q and Dispenzieri, Angela and Dingli, David and Gonsalves, Wilson I and Kumar, Shaji and Kapoor, Prashant and Kourelis, Taxiarchis and Hogan, William J and Gertz, Morie A
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 13, pp. 1323 - 1329
PurposeAutologous stem-cell transplantation (ASCT) has been used in patients with immunoglobulin light chain (AL) amyloidosis for more than two decades. Early... 
STAGING SYSTEM | MULTIPLE-MYELOMA | IMPROVED OUTCOMES | PLUS DEXAMETHASONE | EARLY DEATH | ONCOLOGY | PRIMARY SYSTEMIC AMYLOIDOSIS | HIGH-DOSE MELPHALAN | AL AMYLOIDOSIS | INTENSIVE MELPHALAN | CARDIAC BIOMARKERS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy
by Dingli, David and Ailawadhi, Sikander and Bergsagel, P. Leif and Buadi, Francis K and Dispenzieri, Angela and Fonseca, Rafael and Gertz, Morie A and Gonsalves, Wilson I and Hayman, Susan R and Kapoor, Prashant and Kourelis, Taxiarchis and Kumar, Shaji K and Kyle, Robert A and Lacy, Martha Q and Leung, Nelson and Lin, Yi and Lust, John A and Mikhael, Joseph R and Reeder, Craig B and Roy, Vivek and Russell, Stephen J and Sher, Taimur and Stewart, A. Keith and Warsame, Rahma and Zeldenrust, Stephen R and Rajkumar, S. Vincent and Chanan Khan, Asher A
Mayo Clinic Proceedings, ISSN 0025-6196, 04/2017, Volume 92, Issue 4, pp. 578 - 598
Life expectancy in patients with multiple myeloma is increasing because of the availability of an increasing number of novel agents with various mechanisms of... 
SINGLE-AGENT CARFILZOMIB | MEDICINE, GENERAL & INTERNAL | BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE | RANDOMIZED PHASE-III | COMBINATION THERAPY | CIRCULATING PLASMA-CELLS | LENALIDOMIDE PLUS DEXAMETHASONE | OPEN-LABEL | STEM-CELL TRANSPLANTATION | LOW-DOSE DEXAMETHASONE | ORAL PROTEASOME INHIBITOR | Recurrence | Multiple Myeloma - drug therapy | Long Term Adverse Effects - diagnosis | Multiple Myeloma - diagnosis | Long Term Adverse Effects - therapy | Clinical Decision-Making | Humans | Antineoplastic Agents - pharmacology | Disease Management | Risk Adjustment - methods | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Practice Guidelines as Topic | Practice guidelines (Medicine) | Evaluation | Care and treatment | Diagnosis | Multiple myeloma | Relapse | Health aspects | Diseases | Fees & charges | Transplants & implants | Hematology | Physicians | Research funding | Stem cells | Oncology | Lymphomas | Trends
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Smoldering Waldenström’s macroglobulinemia (SWM): Analysis from the National Cancer Database (NCDB)
by Pophali, Priyanka Avinash and Bartley, Adam C and Kapoor, Prashant and Gonsalves, Wilson I and Ashrani, Aneel A and Marshall, Ariela L and Siddiqui, Mustaqeem Ahmad and Go, Ronald S
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 1573 - 1573
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Three Decades of Autologous Stem Cell Transplantation for Myeloma; Trends in Early Mortality and Survival
by Sidiqi, M Hasib and Aljama, Mohammed A and Dispenzieri, Angela and Muchtar, Eli and Buadi, Francis K and Warsame, Rahma and Lacy, Martha Q and Dingli, David and Leung, Nelson and Gonsalves, Wilson I and Kapoor, Prashant and Kourelis, Taxiarchis and Hogan, William J and Kumar, Shaji K and Gertz, Morie A
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3436 - 3436
Abstract Introduction: Outcomes in multiple myeloma have significantly improved in recent times owing to the availability of newer more effective therapies.... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.